Cruickshank Tim 4
4 · HeartBeam, Inc. · Filed Mar 23, 2026
Research Summary
AI-generated summary of this filing
HeartBeam CFO Tim Cruickshank Receives 53,104-Share Option Award
What Happened
- Tim Cruickshank, Chief Financial Officer of HeartBeam, Inc. (BEAT), received a grant of derivative securities on Feb 9, 2026: options covering 53,104 shares. The Form 4 reports an acquisition price of $0.00 (common for option grants recorded as awards); the award was issued under the company’s 2022 Equity Incentive Plan.
- This is an equity award (grant), not an open-market purchase or sale, so it does not reflect an immediate cash investment or liquidation by the insider.
Key Details
- Transaction date: February 9, 2026. Filing date: March 23, 2026 (filed late relative to the typical 2-business-day Form 4 deadline).
- Reported amount: 53,104 shares (derivative/option award) at $0.00 per share on the Form 4.
- Vesting: Per the filing footnote, half of the shares vest on March 31, 2026 (3 months after vesting commencement dated Jan 1, 2026) and the remainder vest on June 30, 2026 (6 months after that commencement). Options issued from the 2022 Equity Incentive Plan (see footnote F1).
- Shares owned after the transaction are not specified in the provided filing excerpt.
Context
- This is an award/grant of options (derivative securities). Such grants are routine for executive compensation and do not by themselves signal buying or selling intent in the open market.
- The late filing reduces near-term transparency for investors; the underlying economic terms (exercise price, if different from the $0.00 listed, or other plan details) may be clarified in full filings or company disclosures.
Insider Transaction Report
Form 4
HeartBeam, Inc.BEAT
Transactions
- Award
Common Stock (right to buy)
[F1]2026-02-09+53,104→ 53,104 totalExercise: $1.45Exp: 2036-01-01→ Common Stock (53,104 underlying)
Footnotes (1)
- [F1]Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.
Signature
/s/ Tim Cruickshank|2026-03-23